Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.
2.
3.

Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community.

Worley RR, Moore SM, Tierney BC, Ye X, Calafat AM, Campbell S, Woudneh MB, Fisher J.

Environ Int. 2017 Sep;106:135-143. doi: 10.1016/j.envint.2017.06.007. Epub 2017 Jun 20.

PMID:
28645013
4.

Perfluorodecanoic acid stimulates NLRP3 inflammasome assembly in gastric cells.

Zhou X, Dong T, Fan Z, Peng Y, Zhou R, Wang X, Song N, Han M, Fan B, Jia J, Liu S.

Sci Rep. 2017 Apr 3;7:45468. doi: 10.1038/srep45468.

5.

Persistent alterations in immune cell populations and function from a single dose of perfluorononanoic acid (PFNA) in C57Bl/6 mice.

Rockwell CE, Turley AE, Cheng X, Fields PE, Klaassen CD.

Food Chem Toxicol. 2017 Feb;100:24-33. doi: 10.1016/j.fct.2016.12.004. Epub 2016 Dec 8.

6.

Modeled Perfluorooctanoic Acid (PFOA) Exposure and Liver Function in a Mid-Ohio Valley Community.

Darrow LA, Groth AC, Winquist A, Shin HM, Bartell SM, Steenland K.

Environ Health Perspect. 2016 Aug;124(8):1227-33. doi: 10.1289/ehp.1510391. Epub 2016 Mar 15.

7.

Placental Transfer of Perfluoroalkyl Substances and Associations with Thyroid Hormones: Beijing Prenatal Exposure Study.

Yang L, Li J, Lai J, Luan H, Cai Z, Wang Y, Zhao Y, Wu Y.

Sci Rep. 2016 Feb 22;6:21699. doi: 10.1038/srep21699.

8.

Associating Changes in the Immune System with Clinical Diseases for Interpretation in Risk Assessment.

DeWitt JC, Germolec DR, Luebke RW, Johnson VJ.

Curr Protoc Toxicol. 2016 Feb 1;67:18.1.1-18.1.22. doi: 10.1002/0471140856.tx1801s67. Review.

9.

A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humans.

Chang ET, Adami HO, Boffetta P, Wedner HJ, Mandel JS.

Crit Rev Toxicol. 2016;46(4):279-331. doi: 10.3109/10408444.2015.1122573. Epub 2016 Jan 13. Review.

10.

Metabolic Profiling of Chicken Embryos Exposed to Perfluorooctanoic Acid (PFOA) and Agonists to Peroxisome Proliferator-Activated Receptors.

Mattsson A, Kärrman A, Pinto R, Brunström B.

PLoS One. 2015 Dec 1;10(12):e0143780. doi: 10.1371/journal.pone.0143780. eCollection 2015.

11.

Biomonitoring in California firefighters: metals and perfluorinated chemicals.

Dobraca D, Israel L, McNeel S, Voss R, Wang M, Gajek R, Park JS, Harwani S, Barley F, She J, Das R.

J Occup Environ Med. 2015 Jan;57(1):88-97. doi: 10.1097/JOM.0000000000000307.

12.

The mammary gland is a sensitive pubertal target in CD-1 and C57Bl/6 mice following perinatal perfluorooctanoic acid (PFOA) exposure.

Tucker DK, Macon MB, Strynar MJ, Dagnino S, Andersen E, Fenton SE.

Reprod Toxicol. 2015 Jul;54:26-36. doi: 10.1016/j.reprotox.2014.12.002. Epub 2014 Dec 12.

13.

Serum concentrations of perfluorinated compounds (PFC) among selected populations of children and adults in California.

Wu XM, Bennett DH, Calafat AM, Kato K, Strynar M, Andersen E, Moran RE, Tancredi DJ, Tulve NS, Hertz-Picciotto I.

Environ Res. 2015 Jan;136:264-73. doi: 10.1016/j.envres.2014.09.026. Epub 2014 Nov 20.

14.

Modeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohorts.

Winquist A, Steenland K.

Environ Health Perspect. 2014 Dec;122(12):1299-305. doi: 10.1289/ehp.1307943. Epub 2014 Sep 26.

15.

Biomarker-based calibration of retrospective exposure predictions of perfluorooctanoic acid.

Shin HM, Steenland K, Ryan PB, Vieira VM, Bartell SM.

Environ Sci Technol. 2014 May 20;48(10):5636-42. doi: 10.1021/es4053736. Epub 2014 May 1.

16.

Perfluorinated compounds: emerging POPs with potential immunotoxicity.

Corsini E, Luebke RW, Germolec DR, DeWitt JC.

Toxicol Lett. 2014 Oct 15;230(2):263-70. doi: 10.1016/j.toxlet.2014.01.038. Epub 2014 Feb 3. Review.

17.

Polyfluoroalkyl chemicals and menopause among women 20-65 years of age (NHANES).

Taylor KW, Hoffman K, Thayer KA, Daniels JL.

Environ Health Perspect. 2014 Feb;122(2):145-50. doi: 10.1289/ehp.1306707. Epub 2013 Nov 26.

18.

Association between perfluoroalkyl substances and thyroid stimulating hormone among pregnant women: a cross-sectional study.

Wang Y, Starling AP, Haug LS, Eggesbo M, Becher G, Thomsen C, Travlos G, King D, Hoppin JA, Rogan WJ, Longnecker MP.

Environ Health. 2013 Sep 8;12(1):76. doi: 10.1186/1476-069X-12-76.

19.

Reductions in serum lipids with a 4-year decline in serum perfluorooctanoic acid and perfluorooctanesulfonic acid.

Fitz-Simon N, Fletcher T, Luster MI, Steenland K, Calafat AM, Kato K, Armstrong B.

Epidemiology. 2013 Jul;24(4):569-76. doi: 10.1097/EDE.0b013e31829443ee. Erratum in: Epidemiology. 2013 Nov;24(6):941.

20.

Exposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plant.

Watkins DJ, Josson J, Elston B, Bartell SM, Shin HM, Vieira VM, Savitz DA, Fletcher T, Wellenius GA.

Environ Health Perspect. 2013 May;121(5):625-30. doi: 10.1289/ehp.1205838. Epub 2013 Mar 11.

Supplemental Content

Support Center